Precision Oncology Market Size, Top Trends and Forecast 2036
The precision oncology market was valued at USD 137.39 billion in 2026 and is projected to reach USD 337.39 billion by the end of 2036, registering a CAGR of around 9.4% during 2027-2036. Market expansion is being driven by the increasing adoption of molecular profiling, genomic analysis, targeted treatment strategies, and biomarker-guided cancer management. The growing emphasis on personalized treatment and improved patient stratification is also encouraging healthcare providers and pharmaceutical companies to invest in precision oncology technologies.
